IRIS
GRANDALIANO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.369
EU - Europa 4.853
AS - Asia 2.456
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
SA - Sud America 7
Totale 12.708
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.348
CN - Cina 1.806
IE - Irlanda 1.701
UA - Ucraina 1.280
SE - Svezia 723
IT - Italia 308
FI - Finlandia 242
IN - India 242
FR - Francia 212
SG - Singapore 198
TR - Turchia 157
DE - Germania 156
GB - Regno Unito 111
CZ - Repubblica Ceca 40
BE - Belgio 35
KR - Corea 21
CA - Canada 20
RU - Federazione Russa 16
EU - Europa 14
NL - Olanda 11
PK - Pakistan 11
ES - Italia 9
AU - Australia 7
CL - Cile 5
JP - Giappone 5
IQ - Iraq 3
RO - Romania 3
SA - Arabia Saudita 3
BR - Brasile 2
IR - Iran 2
MY - Malesia 2
PL - Polonia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EE - Estonia 1
GR - Grecia 1
HK - Hong Kong 1
ID - Indonesia 1
JO - Giordania 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
Totale 12.708
Salva come PNG Salva come JPEG
Città #
Dublin 1.701
Chandler 1.022
Jacksonville 910
Dearborn 532
Nyköping 484
Nanjing 463
Wilmington 214
Beijing 210
Ashburn 206
Nanchang 191
Princeton 188
San Mateo 181
Singapore 138
New York 126
Shenyang 120
Boardman 111
Ann Arbor 96
Hebei 83
Des Moines 76
Helsinki 75
Jiaxing 74
Kunming 65
Changsha 64
Tianjin 61
Jinan 48
Hangzhou 41
Pune 40
Woodbridge 40
Munich 39
Shanghai 39
Ningbo 37
Brno 35
Guangzhou 33
Zhengzhou 33
Brussels 32
Foggia 31
Taizhou 30
Los Angeles 26
Hilden 24
Seattle 24
Lanzhou 20
Auburn Hills 18
Wuhan 16
Augusta 15
Bari 15
Orange 15
Changchun 14
Rome 14
Norwalk 12
Falls Church 11
Lahore 11
Toronto 11
Fuzhou 10
Leawood 10
Washington 10
Saint Petersburg 9
Shenzhen 9
Milan 7
San Francisco 7
Bologna 6
Haikou 6
Hefei 6
Jinhua 5
London 5
Padova 5
Paris 5
Redwood City 5
Bisceglie 4
Borås 4
Clifton 4
Dongyang 4
Kolkata 4
Murcia 4
Olomouc 4
Palese 4
Rockville 4
Stevenage 4
Xuzhou 4
Amsterdam 3
Avigliano 3
Baghdad 3
El Segundo 3
Florence 3
Genova 3
Kocaeli 3
Melbourne 3
Mountain View 3
Noicattaro 3
Philadelphia 3
Redmond 3
Rui'an 3
Santa Clara 3
Shaoxing 3
Wuhu 3
Bangalore 2
Bitetto 2
Bitonto 2
Brescia 2
Buffalo 2
Canosa Di Puglia 2
Totale 8.324
Salva come PNG Salva come JPEG
Nome #
Metodo per il dosaggio del fattore di crescita epidermico (EGF) e del peptide-1 chemiotattico dei monociti umani (MCP-1) in un campione biologico e relativo kit diagnostico 201
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 133
La riduzione dei livelli sierici di BAFF e APRIL si associa alla negativizzazione degli anticorpi anti-recettore della fosfolipasi A2 (PLA2R) nei pazienti affetti da glomerulonefrite membranosa idiopatica (iMN) 121
The role of alpha-smooth muscle actin and platelet-derived growth factor-beta receptor in the progression of renal damage in human IgA nephropathy. 115
Activated coagulation factor X: a novel mitogenic stimulus for human mesangial cells 114
The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. 113
Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? 109
Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy. 108
High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. 104
“Urinary excretion and renal expression of monocyte chemotactive peptide-1 (MCP-1) and epidermal growth factor expression (EGF) in children with reflux and obstructive nephropathies 103
Sirolimus interferes with iron homeostasis in renal transplant recipients 102
“Urinary epidermal growth factor (EGF) concentration in children affected by severe obstructive and reflux uropathy”. 101
ADAMTS13 MUTATIONS AND POLYMORPHISMS IN CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA. 101
[Cardiovascular risk in polycystic kidney disease] 101
Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes 100
PROSTATE CANCER IS CHARACTERIZED BY A DYSREGULATION OF THE IMMUNE RESPONSE 100
ESCREZIONE URINARIA DI MONOCYTE CHEMOTACTIC PEPTIDE-1 ED EPIDERMAL GROWTH FACTOR NELL’UROPATIA OSTRUTTIVA IN ETÀ PEDIATRICA 99
Atti 52° Congresso Nazionale della Società Italiana di Nefrologia. Genova, 21-24 Settembre, 2011 99
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 99
Additive effect of cyclosporine and low density lipoproteins on transforming growth factor-beta 1 and monocyte chemotactic protein-1 expression in human mesangial cells. 98
Espressione renale di epidermal growth factor (EGF) e monocyte chemotactic peptide-1 (MCP-1) in bambini affetti da stenosi del giunto pielo-ureterale. 94
“Espressione renale della proteina chemotattica per i monociti (MCP-1) e del fattore di crescita epidermico (EGF) in bambini affetti da stenosi del giunto pielo-ureterale (SGPU).” 94
A novel biologic activity of thrombin: stimulation of monocyte chemotactic protein production. 94
Epidemal growth factor and monocyte chemotactic protein-1 renal expression and urinary levels in pediatric ureteropelvic junction obstruction 92
Creazione di un database multimediale per la gestione della telepatologia statica e della telemorfometria nella immunopatologia renale 91
Renal cortical complement C3 gene expression in IgA nephropathy 91
Monocyte recruitment in cryoglobulinemic membranoproliferative glomerulonephritis: a pathogenetic role for monocyte chemotactic peptide-1. 90
Fibrin down-regulates LPS- and PMA- induced tissue factor expression by blood mononuclear cells. 89
“Epidermal growth factor (EGF) and monocyte chemotactic peptide-1 (MCP-1) renal expression in children affected by ureteropelvic junction obstruction” 89
Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells 88
Incidence of anemia in sirolimus-treated renal transplant recipients: the importance of preserving renal function. 88
Proteomic profile of plasma proteins eluted from Coupled Plasma Filtration-Adsorption (CPFA) sorbent resin cartridges in a swine model of sepsis 88
High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients. 87
La Fetuina A è ridotta nel siero e nelle urine dei pazienti affetti da nefro-urolitiasi ricorrente 87
Espressione renale e livelli urinari di fattore di crescita epidermico ed proteina chemotattica dei monociti-1 in bambini con stenosi del giunto pielo-ureterale 86
Sirolimus and angiotensin-converting enzyme inhibitors together induce tongue oedema in renal transplant recipients 86
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 86
Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection 85
Altered urinary excretion of aquaporin 2 in IgA nephropathy. 85
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. 84
Proteomic profile of CD24+ CD133+ renal multipotent progenitors (RMP) 84
Clinical and therapeutic aspects of diabetic nephropathy 84
Angiotensin Inhibition Mycophenolate mophetil IgA Nephropathy study investigators. One-year angiotensin-converting enzyme inhibition plus mycophenolate mofetil immunosuppression in the course of early IgA nephropathy: a multicenter, randomised, controlled study. 83
Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients. 82
Cardiovascular risk and renal transplantation 82
Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis 82
Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression 82
A study on glucose metabolism in a small cohort of children and adolescents with kidney transplant. 82
Protease-activated receptor 1 and plasminogen activator inhibitor 1 expression in chronic allograft nephropathy. 81
Acute renal failure in critically ill patients. 81
Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction 81
INCREASE OF PROLIFERATING RENAL PROGENITOR CELLS IN ACUTE TUBULAR NECROSIS UNDERLYING DELAYED GRAFT FUNCTION IN KIDNEY TRANSPLANTATION 81
Placental imbalance of vasoactive factors does not affect pregnancy outcome in patients treated with cyclosporine A after transplant 80
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 80
Thrombin: a novel renal growth factor. 79
Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells. 79
Anti-Fibrotic Effect of Mycophenolic Acid-Induced Neutral Endopeptidase. 79
Children with obstructive uropathy showed renal overexpression of plasminogen activator inhibitor-1 unrelated to renal expression of angiotensinogen 78
A single-center cohort study to define the role of pretransplant biopsy score in the long-term outcome of kidney transplantation 78
Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy. 78
Espressione renale di PAI-1 (Plasminogen activator inhibitor-1) ed angiotensinogeno (AGT) in bambini con nefropatia ostruttiva (NO). 77
mTOR inhibitors effects on regulatory T cells and on dendritic cells 77
Acute kidney injury in the elderly population. 76
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 76
Rapamycin treatment for benign multicystic peritoneal mesothelioma: A rare disease with a difficult management 76
A novel SMARCAL1 mutation associated with a mild phenotype of Schimke immuno-osseous dysplasia (SIOD) 76
Rapamycin Inhibits PAI-1 Expression and Reduces Interstitial Fibrosis and Glomerulosclerosis in Chronic Allograft Nephropathy 75
Platelet-leukocyte interactions in hemodialysis patients: culprit or bystander? 75
MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy 74
Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function 74
Exposure to low- vs. iso-osmolar contrast agents induces NADPH-dependent Reactive Oxygen Species (ROS) genereration in a cellular model of renal injur 73
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: A multicentre prospective study in renal clinics 73
Cyclosporin exposure correlates with 1 year graft function and histological damage in renal transplanted patients 72
Cytokines and bioincompatibility 72
Thrombin regulates expression of monocyte chemoattractant protein-1 in vascular smooth muscle cells. 71
Trapianto di rene doppio. Analisi retrospettiva dei dati relativi alla popolazione dei pazienti portatori di trapianto renale doppio in ambito AIRT 71
Inflammation and carnitine in hemodialysis patients. 71
Actions of platelet-derived growth factor isoforms in mesangial cells. 71
Allograft nephrectomy: what is the best surgical technique? 71
Angiotensin IV and renal diseases. 70
“Monocyte chemotatic protein-1 and epidermal growth factor (EGF) expression and secretion in xanthogranulomatous pyelonephritis 70
BMP-2 INDUCES A PRO-FIBROTIC PHENOTYPE IN DULT RENAL PROGENITOR CELLS THROUGH Nox4 ACTIVATION. 70
Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation 70
Treatment with rituximab in idiopathic membranous nephropathy 69
Ramipril inhibits in vitro human mesangial cell proliferation and platelet-derived growth factor expression. 68
Clinical relevance of citokine production in hemodialysis. 67
Ischemia-reperfusion induces glomerular and tubular activation of pro-inflammatory and anti-apoptotic pathways: differential modulation by rapamycin. 67
In vivo modulation of soluble "antagonistic" IL-6 receptor synthesis and release in ESRD. 67
PROTEOMIC PROFILE OF CD24+CD133+RENAL MULTIPOTENT PROGENITORS (RMP) 67
Immunohistochemical characterization of glomerular and tubulointerstitial infiltrates in renal transplant patients with chronic allograft dysfunction. 66
Management and prevention of post-transplant malignancies in kidney transplant recipients 66
The role of hyperparathyroidism, erythropoietin therapy, and CMV infections in the failure of arteriovenous fistula in hemodialysis. 65
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis 65
Management of Side Effects of Sirolimus Therapy. 64
The role of tubular cells in the progression of renal damage: guilty or innocent? 64
Vitamin E-modified filters modulate Jun N-terminal kinase activation in peripheral blood mononuclear cells. 64
Rapamycin induces ILT3highILT4high dendritic cells promoting a new immunoregulatory pathway 64
Renal injury after low-or iso-osmolar contrast agent exposure:an in vitro study 64
Recidive della nefropatia di base e nefropatie “de novo” in pazienti portatori di trapianto renale 63
Early withdrawal of cyclosporine improves 1-year kidney graft structure and function in Sirolimus-treated patients: Response to the authours 61
Totale 8.403
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.840
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.840
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.675 0 0 0 0 333 312 452 35 244 42 234 23
2020/20211.460 197 8 190 10 187 100 214 61 209 269 12 3
2021/2022963 171 3 39 15 63 16 17 76 123 112 35 293
2022/20234.137 375 200 243 247 221 353 37 297 1.976 18 66 104
2023/2024810 92 22 37 32 53 278 68 60 4 11 13 140
2024/2025449 170 15 113 102 49 0 0 0 0 0 0 0
Totale 12.963